Home > IPO > Many cancer drugs remain unproven 5 years after accelerated approval, a study finds Article

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

2025-05-09 12:22:56 Source:Grant Preston Author:Zukunft Click:697 times

Dominican Republic Will Close Border With Haiti Amid Water Dispute

New investments worth INR 2,755 cr pledged with Indian Biogas AssociationDiscounts offered on Russian crude oil double in 2 months

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

UK plan to lead in generative AI ‘unrealistic,’ say Cambridge researchers2023 Honda CB300R launched at INR 2.40 lakh; gets OBD2A complianceAudi India launches S5 Sportback Platinum Edition at INR 81.57 lakh for festive season

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

Sidbi announces growth accelerator programme for small NBFCsAs India frowns on paying for Russian oil with yuan, some payments held up, sources say

Many cancer drugs remain unproven 5 years after accelerated approval, a study finds

Tesla earnings: investors watching margins, deliveries, self-driving

Royal Enfield launches first of its kind buyback program with OTO CapitalE-bus battery swap norms likely to roll out soon

TEA Business College ranked among the top ten business leaders in "PRIME VIEW"European startups are making batteries both punchy — and portable

Drone company IdeaForge to enter new segmentDo You Know These Novels and Their Recent Television Adaptations?

Author:Marktblick
------分隔线----------------------------
Hot News
Picture News
Rank